![Robert Levak](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Levak
Director/Board Member at Voxcell Bioinnovation, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Karolina Valente | M | - |
Voxcell Bioinnovation, Inc.
![]() Voxcell Bioinnovation, Inc. Industrial MachineryProducer Manufacturing Voxcell Bioinnovation, Inc. is a Canadian company that creates solutions for the drug development industry and Oncology research. The company is based in Victoria, Canada. The company offers a range of products including Novel Bioinks, Truly Biomimetic Tissue Models for in vitro drug testing, and a unique super high resolution 3D Bioprinter. The company was founded by Karolina Valente and she has been the CEO since incorporation. | 4 years |
Sandra E. Dunn | M | - |
Phoenix Molecular Designs Ltd.
![]() Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | 12 years |
Aarthi Jayanthan | M | - |
Phoenix Molecular Designs Ltd.
![]() Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | 9 years |
Janet Grove | F | 57 |
Phoenix Molecular Designs Ltd.
![]() Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | - |
Julia G. Levy | M | 89 |
Phoenix Molecular Designs Ltd.
![]() Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | - |
Magda Marquet | M | 65 |
Phoenix Molecular Designs Ltd.
![]() Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | 5 years |
Steven J. Potts | M | - |
Phoenix Molecular Designs Ltd.
![]() Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | - |
Christopher Bissonnette | M | - |
Phoenix Molecular Designs Ltd.
![]() Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | 6 years |
Lana Janes | M | - |
Phoenix Molecular Designs Ltd.
![]() Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | - |
David A. Schellenberg | M | 60 |
Phoenix Molecular Designs Ltd.
![]() Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | - |
Alan Ashworth | M | 63 |
Phoenix Molecular Designs Ltd.
![]() Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | - |
Nina Vellani | M | - |
Voxcell Bioinnovation, Inc.
![]() Voxcell Bioinnovation, Inc. Industrial MachineryProducer Manufacturing Voxcell Bioinnovation, Inc. is a Canadian company that creates solutions for the drug development industry and Oncology research. The company is based in Victoria, Canada. The company offers a range of products including Novel Bioinks, Truly Biomimetic Tissue Models for in vitro drug testing, and a unique super high resolution 3D Bioprinter. The company was founded by Karolina Valente and she has been the CEO since incorporation. | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
David Crean | M | 59 |
Phoenix Molecular Designs Ltd.
![]() Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | - |
Statistics
Country | Connections | % of total |
---|---|---|
Canada | 13 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Robert Levak
- Personal Network